The UDP/P2y6 Axis Promotes Lung Metastasis of Melanoma by Remodeling the Premetastatic Niche

Juliang Qin,Zhen Zhang,Zhixiang Fu,Hua Ren,Mingyao Liu,Min Qian,Bing Du

DOI: https://doi.org/10.1038/s41423-020-0392-0

2020-01-01

Abstract:Tumor metastasis is the major cause of death in cancer patients,in which tumor cells progressively migrate from a primary site to distant organs.Although there are multiple steps in the tumor metastatic process,growing evidence indicates that one vital step in metastasis is paracrine alteration of distant tissues by the primary tumor,allowing metastatic colonization of an area hospitable to the cancer cells,termed the premetastatic niche,1 which is consistent with the"seed and soil"hypothesis.In this case,prometastatic tumor cells("seeds")colonize the metastatic tissue("congenial soil")in which the microenvironment has been altered by diverse signaling molecules to modulate cellular components,especially bone marrow-derived immune cells.2-4 It is well known that the nucleotide signaling network plays an important role in inflammation and the tumor microenvironment by regulating various immune cells.5,6 Extracellular nucleosides(adenosine)and nucleotides(ATP,ADP,UTP,UDP,and sugar UDP)function as signaling molecules by activating nucleotide receptors,including P1 receptors and P2 receptors.The purinergic P2 receptors are divided into ionotropic P2X receptors and metabo-tropic P2Y receptors,which are members of the G-protein-coupled receptor family.7 Our previous study showed that chemotherapy-induced extracellular UDP release can activate the P2y6 receptor on breast tumor cells to facilitate breast cancer metastasis.8 However,the role and mechanism of UDP/P2y6 signaling in the premetastatic immune microenvironment during the tumor metastatic process is poorly understood.